Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Busulfan tablets | For hospital use only |
|
|
C1 Esterase Inhibitor (Cinryze®, Berinert®) | NHS England commissioned. Hospital only. |
|
|
Cabozantinib | ||
|
Cade oil 12% w/w and salicylic acid 6% w/w in emulsifying ointment | Unlicensed special |
|
|
Caffeine | Hospital only |
|
 |
Calcium tablets (calcium - 500 Phosex) | Specialist recommendation. |
|
 |
Canesten HC cream | Mild steroid potency. |
|
|
Caphosol oral rinse | Oncology and haematology only. |
|
|
Capsaicin (Zacin, Axsain) | Very high relative cost, Tier 2 |
|
|
Capsaicin cream 0.075% | Only strength licensed for post-herpetic neuralgia and diabetic peripheral polyneuropathy. |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
